☆ 4.7 Article

In silico screening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms

Fei Li et al.

Summary: Bladder cancer is a common malignancy worldwide, and cisplatin-based combination chemotherapies have become important adjuvant therapies. However, the development of chemoresistance limits the effectiveness of cisplatin treatment. Epigenetic modifications, such as DNA methylation and noncoding RNA regulation, have been found to be involved in cisplatin resistance, and epigenetic biomarkers have been applied for patient screening and monitoring.

DRUG RESISTANCE UPDATES (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy

Yujia Liu et al.

Summary: Thyroid cancer, especially the differentiated subtype, can be cured with surgery and radioactive iodine therapy. However, a significant proportion of patients develop resistance to radioactive iodine treatment, leading to poor prognosis. Understanding the mechanisms of iodine resistance and improving sensitization strategies are still necessary to enhance the effectiveness and safety of treatment.

DRUG RESISTANCE UPDATES (2023)

添加到收藏夹

Review Chemistry, Medicinal

Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products

Holya A. Lafta et al.

Summary: Tumor-associated macrophages (TAMs) play a crucial role in tumor progression and resistance to anticancer drugs. TAMs can modulate the tumor microenvironment (TME) to promote immune system exhaustion. The interactions between TAMs and TME can affect the function of cytotoxic CD8+ T lymphocytes (CTLs) and natural killer (NK) cells.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Oncology

AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

Yuqing Zhang et al.

Summary: Pancreatic cancer is a major cause of cancer-related deaths in the US, with resistance to therapy and immunosuppressive microenvironment being major challenges. The AXL inhibitor TP-0903 shows anti-tumor and sensitizing effects in preclinical models of pancreatic cancer, leading to improved prognosis and immune activation.

MOLECULAR CANCER THERAPEUTICS (2022)

添加到收藏夹

Article Chemistry, Medicinal

Maximum Common Substructure Searching in Combinatorial Make-on-Demand Compound Spaces

Robert Schmidt et al.

Summary: Commercial make-on-demand compound spaces are increasingly popular, but existing search methods lack the ability to search for precise structural features on the atomic level. To address this, researchers developed a method called SpaceMACS for efficient and precise similarity and substructure searches within chemical fragment spaces. They applied SpaceMACS to commercial fragment spaces and successfully found analogs and synthesis suggestions.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

添加到收藏夹

Review Oncology

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects

Solange Peters et al.

Summary: Lung cancer, especially non-small-cell lung cancer (NSCLC), is a major cause of cancer death. The immunosuppressive tumor microenvironment (TME) plays a crucial role in developing resistance to immune checkpoint inhibitors (CPIs) for NSCLC. Targeting TAM receptors and immune checkpoints simultaneously may overcome CPI resistance and improve survival rates for lung cancer patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Editorial Material Oncology

AACR Cancer Progress Report 2021: Discovery Science Driving Clinical Breakthroughs

Rajarshi Sengupta et al.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Meeting Abstract Oncology

Activity of the TAM kinase-targeting compound, SLC-391, is mediated by the engagement of the immune system in CT-26 syngeneic mouse model

Shenshen Lai et al.

MOLECULAR CANCER THERAPEUTICS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase

Ketan S. Gajiwala et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

添加到收藏夹

Article Oncology

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

Maurizio Scaltriti et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Article Chemistry, Physical

Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power

Zhe Wang et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)

添加到收藏夹

Article Oncology

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance

Miles A. Miller et al.

CANCER DISCOVERY (2016)

添加到收藏夹

Meeting Abstract Oncology

A first in human phase I study of receptor tyrosine kinase (RTK) inhibitor MGCD516 in patients with advanced solid tumors.

Todd Michael Bauer et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Biochemical Research Methods

Fast, accurate, and reliable molecular docking with QuickVina 2

Amr Alhossary et al.

BIOINFORMATICS (2015)

添加到收藏夹

Article Chemistry, Medicinal

g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations

Rashmi Kumari et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith Mueller et al.

NATURE COMMUNICATIONS (2014)

添加到收藏夹

Review Oncology

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

Douglas K. Graham et al.

NATURE REVIEWS CANCER (2014)

添加到收藏夹

Article Chemistry, Medicinal

Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise

David Ryan Koes et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

添加到收藏夹

Article Chemistry, Medicinal

Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking

Michael M. Mysinger et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

添加到收藏夹

Article Oncology

Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma

Xianzhou Song et al.

CANCER (2011)

添加到收藏夹

Article Chemistry, Medicinal

Efficient Substructure Searching of Large Chemical Libraries: The ABCD Chemical Cartridge

Dimitris K. Agrafiotis et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)

添加到收藏夹

Review Oncology

Targeting Axl and Mer Kinases in Cancer

Anupam Verma et al.

MOLECULAR CANCER THERAPEUTICS (2011)

添加到收藏夹

Article Chemistry, Multidisciplinary

Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading

Oleg Trott et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)

添加到收藏夹

Article Oncology

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Li Liu et al.

CANCER RESEARCH (2009)

添加到收藏夹

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Wenjun Zhou et al.

NATURE (2009)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

J Stamos et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.